SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-234615
Filing Date
2022-08-31
Accepted
2022-08-31 08:00:55
Documents
13
Period of Report
2022-08-30
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d372213d8k.htm   iXBRL 8-K 25879
2 EX-99.1 d372213dex991.htm EX-99.1 128946
  Complete submission text file 0001193125-22-234615.txt   295565

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bhc-20220830.xsd EX-101.SCH 2535
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bhc-20220830_lab.xml EX-101.LAB 18799
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bhc-20220830_pre.xml EX-101.PRE 11780
7 EXTRACTED XBRL INSTANCE DOCUMENT d372213d8k_htm.xml XML 3498
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 221216293
SIC: 2834 Pharmaceutical Preparations